Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-11-016674)

Filing Details

Accession Number:: 0001127602-11-016674
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-17 18:13:22
Reporting Period:: 2011-05-13

Filing Date:: 2011-05-17
Accepted Time:: 2011-05-17 18:13:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874663	Alkermes Inc	ALKS	Pharmaceutical Preparations (2834)	232472830

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236441	A Robert Breyer	852 Winter St. Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-13	3,025	$7.19	73,231	No	4	M	Direct
Common Stock	Disposition	2011-05-13	3,025	$18.00	70,206	No	4	S	Direct
Common Stock	Disposition	2011-05-13	3,025	$18.00	67,181	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non Qualified Stock Option (Right to Buy)	Disposition	2011-05-13	3,025	$0.00	3,025	$7.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,475	2003-03-18	2012-09-18	No	4	M	Direct

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This option became exercisable in full six months from the date of grant.